Independent peptide newsroom

The update matters. The original source matters more.

Follow material developments in research, regulation, compounding, safety, and industry. Reports link back to the document, record, or study behind the headline.

Top stories

What changed, and what did not.

Dates, scope, and uncertainty stay visible so a fast-moving story does not outrun its evidence.

100 focused news answers

Read breaking developments with better context.

Learn how reports handle primary sources, FDA action, trial results, compounding, corrections, attribution, and submissions.

Open the news FAQ